Turns out he's Jewish. Our Santa, anyway. Even though he doesn't celebrate Christmas, our Dr. Robert Sinkin has donned the jolly red suit each year for the last 12 years to bring a little happiness to families that could definitely use some. UVA Today has done a tremendously charming piece…
A troubling new study from our Timothy Showalter, MD, points out that providing brachytherapy for advanced cervical cancer actually costs hospital money. And that may explain the declining use of it at many facilities, even though it's the gold-standard treatment. “Studies have time and time again shown that brachytherapy is…
Our Robert Carey, MD, was a lead architect of new guidelines that lower the definition of high blood pressure. The change means almost half of U.S. adults have high blood pressure. Dr. Carey, the former dean of the School of Medicine, talked to the New York Times for its story…
In addition to doing science, researchers spend a lot of time and effort trying to get funding to do their science. A program at the School of Medicine is changing that for some faculty who are doing exciting work. The Pinn Scholars program is named for Vivian Pinn, MD, whom…
Macular degeneration robs millions of people of their sight, and now we know what triggers the inflammation that causes it. That raises the exciting possibility we can stop it. Our Jayakrishna Ambati, MD, (at left in the picture) and Nagaraj Kerur, PhD, have identified a specific enzyme that triggers the…
In the focused ultrasound trials I've told you about previously, the point has been to use the scalpel-free surgery to destroy tissue. Our latest trial -- for metastatic breast cancer -- puts an interesting twist on that. In this trial, the focused ultrasound isn't used in an attempt to burn…
